The characteristics of SARS-CoV-2-positive children in Australian hospitals: a PREDICT network study.


Journal

The Medical journal of Australia
ISSN: 1326-5377
Titre abrégé: Med J Aust
Pays: Australia
ID NLM: 0400714

Informations de publication

Date de publication:
05 06 2023
Historique:
revised: 16 03 2023
received: 09 09 2022
accepted: 16 03 2023
medline: 6 6 2023
pubmed: 23 4 2023
entrez: 22 04 2023
Statut: ppublish

Résumé

To examine the clinical characteristics and short term outcomes for children with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections who presented to Australian hospitals during 2020 and 2021. Retrospective case review study in nineteen hospitals of the Paediatric Research in Emergency Departments International Collaborative (PREDICT) network from all Australian states and territories, including seven major paediatric tertiary centres and eight Victorian hospitals. SARS-CoV-2-positive people under 18 years of age who attended emergency departments or were admitted to hospital during 1 February 2020 - 31 December 2021. Epidemiological and clinical characteristics, by hospital care type (emergency department [ED] or inpatient care). A total of 1193 SARS-CoV-2-positive children and adolescents (527 girls, 44%) attended the participating hospitals (107 in 2020, 1086 in 2021). Their median age was 3.8 years (interquartile range [IQR], 0.8-11.4 years); 63 were Aboriginal or Torres Strait Islander people (5%). Other medical conditions were recorded for 293 children (25%), including asthma (86, 7%) and premature birth (68, 6%). Medical interventions were not required during 795 of 1181 ED presentations (67%); children were discharged directly home in 764 cases (65%) and admitted to hospital in 282 (24%; sixteen to intensive care units). The 384 admissions to hospital (including 102 direct admissions) of 341 children (25 infants under one month of age) included 23 to intensive care (6%); the median length of stay was three days (IQR, 1-9 days). Medical interventions were not required during 261 admissions (68%); 44 children received respiratory support (11%) and 21 COVID-19-specific treatments, including antiviral and biologic agents (5%). Being under three months of age (v one year to less than six years: odds ratio [OR], 2.6; 95% confidence interval [CI], 1.7-4.0) and pre-existing medical conditions (OR, 2.5; 95% CI, 1.9-3.2) were the major predictors of hospital admission. Two children died, including one without a known pre-existing medical condition. During 2020 and 2021, most SARS-CoV-2-positive children and adolescents who presented to participating hospitals could be managed as outpatients. Outcomes were generally good, including for those admitted to hospital.

Identifiants

pubmed: 37087105
doi: 10.5694/mja2.51934
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

460-466

Subventions

Organisme : National Health and Medical Research Council
ID : 1124468 F.Babl
Organisme : National Health and Medical Research Council
ID : 1171228

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2023 The Authors. Medical Journal of Australia published by John Wiley & Sons Australia, Ltd on behalf of AMPCo Pty Ltd.

Références

J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Aust Health Rev. 2022 Oct;46(5):529-536
pubmed: 35787299
Nat Commun. 2022 May 24;13(1):2884
pubmed: 35610217
Med J Aust. 2021 Sep 6;215(5):217-221
pubmed: 34389995
Emerg Med Australas. 2020 Oct;32(5):801-808
pubmed: 32390285
Lancet. 2022 Jan 29;399(10323):437-446
pubmed: 35065011
Swiss Med Wkly. 2022 May 27;152:w30185
pubmed: 35748304
Arch Dis Child. 2022 Mar;107(3):e1
pubmed: 34732388
Nat Commun. 2021 Feb 17;12(1):1084
pubmed: 33597531
Emerg Med Australas. 2022 Feb;34(1):85-91
pubmed: 34708565
Aust N Z J Psychiatry. 2023 Apr;57(4):511-519
pubmed: 35757939
JAMA Netw Open. 2022 Jan 4;5(1):e2142322
pubmed: 35015063
Med J Aust. 2022 Sep 19;217(6):303-310
pubmed: 35851698
Commun Dis Intell (2018). 2020 Feb 6;44:
pubmed: 32027812
Arch Dis Child. 2020 Dec 1;:
pubmed: 33262177
Med J Aust. 2022 Mar 21;216(5):255-263
pubmed: 34689329
Ann Emerg Med. 2014 Sep;64(3):292-8
pubmed: 24746846
Int J Public Health. 2022 Jun 17;67:1604553
pubmed: 35814735
Commun Dis Intell (2018). 2021 Dec 20;45:
pubmed: 34923934

Auteurs

Laila Ibrahim (L)

Royal Children's Hospital, Melbourne, Melbourne, VIC.
Murdoch Children's Research Institute, Melbourne, VIC.

Catherine Wilson (C)

Murdoch Children's Research Institute, Melbourne, VIC.
PREDICT Research Network, Melbourne, VIC.

Doris Tham (D)

Murdoch Children's Research Institute, Melbourne, VIC.
Western Health, Melbourne, VIC.

Mark Corden (M)

Northern Hospital Epping, Melbourne, VIC.

Shefali Jani (S)

The Children's Hospital at Westmead, Sydney, NSW.
The Children's Hospital at Westmead Clinical School, the University of Sydney, Sydney, NSW.

Michael Zhang (M)

PREDICT Research Network, Melbourne, VIC.
John Hunter Hospital, Newcastle, NSW.

Amit Kochar (A)

Women's and Children's Hospital, Adelaide, SA.

Ker Fern Tan (KF)

Auburn Hospital, Sydney, NSW.
University of Notre Dame, Sydney, NSW.

Shane George (S)

Gold Coast University Hospital, Gold Coast, QLD.
Child Health Research Centre, the University of Queensland, Brisbane, QLD.

Natalie T Phillips (NT)

Child Health Research Centre, the University of Queensland, Brisbane, QLD.
Queensland Children's Hospital, Brisbane, QLD.

Paul Buntine (P)

Eastern Health, Melbourne, VIC.
Eastern Health Clinical School, Monash University, Melbourne, VIC.

Karen Robins-Browne (K)

University Hospital Geelong, Geelong, VIC.

Vimuthi Chong (V)

Austin Hospital, Melbourne, VIC.

Thomas Georgeson (T)

Canberra Hospital, Canberra, ACT.

Anna Lithgow (A)

Royal Darwin and Palmerston Hospital, Darwin, NT.

Sarah Davidson (S)

Sunshine Coast University Hospital, Sunshine Coast, QLD.

Sharon O'Brien (S)

Perth Children's Hospital, Perth, WA.
Curtin University, Perth, WA.

Viet Tran (V)

Royal Hobart Hospital, Hobart, TAS.
Tasmanian School of Medicine, University of Tasmania, Hobart, TAS.

Franz E Babl (FE)

Murdoch Children's Research Institute, Melbourne, VIC.
The University of Melbourne, Melbourne, VIC.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH